Original Scientific Articles
Journal of Structural Heart Disease, February 2016, Volume 2, Issue 1:33-34
Current Status of Percutaneous Pulmonic Valve Therapies: The Melody Valve
Pediatric Cardiology, Leuven University, UZ Leuven, Herestraat 49, Leuven, Belgium
Transcatheter percutaneous pulmonary valve implantation (PPVI) was first described in 2000 by Philip Bonhoeffer et al 1 as an alternative to open-heart surgery to prolong survival of a right ventricular outflow tract (RVOT) valve conduit.
Since then multiple studies have documented the short term benefits of PPVI implantation using the Melody™ valved stent (Medtronic Inc, Minneapolis, USA) for dysfunctional right ventricle to pulmonary artery (RV-AP) conduits.
This review discusses the development, current status and future endeavors of the Melody valve in the pulmonic position.
Video 1PPVI: PO Fallot. 6F Multitrack over 0.035” E-wire; shrunken 25 mm homograft
Video 2PPVI: PO Fallot. 6F Multitrack over 0.035” E-wire; shrunken 25 mm homograft
Video 3PPVI: PO Fallot. Interrogate with 20 mm balloon over 0.035” E-wire; Ao root angiogram
Video 4PPVI: PO Fallot. Interrogate with 20 mm balloon over 0.035” E-wire; Ao root angiogram
Video 5PPVI: PO Fallot. 45 mm CCP stent on 24 mm BIB through 14 F Cook sheath
Video 6PPVI: PO Fallot. 45 mm CCP stent on 24 mm BIB through 14 F Cook sheath
Video 7PPVI: PO Fallot. Control angiogram through 14 F sheath.
Video 8PPVI: PO Fallot. Control selective angiogram: ? LAD
Video 9PPVI: PO Fallot. Control selective angiogram: ? LAD
Video 10PPVI: PO Fallot. Dilation with 22 mm Atlas Gold up to 20 atm.
Video 11PPVI: PO Fallot. Control selective LCA angiogram: ? LAD
Video 12PPVI: PO Fallot. PPVI of Melody with 22 mm Ensemble
Cite this article as: Gewillig M. Current Status of Percutaneous Pulmonic Valve Therapies: The Melody Valve. Structural Heart Disease 2016;2(1):33-34. DOI: 10.12945/j.jshd.2016.012.14
You must be registered and logged in to leave comments.
There have been no comments posted yet
All comments will be screened and reviewed before posting. Statements, opinions, and results of studies published in Journal of Structural Heart Disease are those of the authors and do not reflect the policy or position of The Journal and Science International and the Editorial Board and provides no warranty as to their accuracy or reliability. Material is copyrighted and owned by Science International and cannot be used without expressed permission.